Clearside Biomedical to Report 2018 Financial Results and Provide Corporate Update on Tuesday, March 12, 2019
27 Februar 2019 - 1:05PM
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical
company dedicated to developing treatments that restore and
preserve vision for people with serious eye diseases, announced
today that its fourth quarter and year end 2018 financial results
will be reported on Tuesday, March 12, 2019 after the close of the
financial markets. Management will host a webcast and
conference call at 5:00 p.m. Eastern Time to discuss the results
and provide a corporate update.
The live and archived webcast may be accessed on
the Clearside website under the Investors section: Events and
Presentations. The live call can be accessed by dialing (844)
263-8310 (domestic) or (213) 358-0959 (international) and entering
conference code: 1855758. An archive of the webcast will be
available for three months.
About Clearside Biomedical
Clearside Biomedical, Inc. is a
biopharmaceutical company dedicated to developing treatments that
restore and preserve vision for people with serious eye diseases.
Clearside’s proprietary suprachoroidal treatment approach offers
unprecedented access to the back of the eye where sight-threatening
disease often occurs. The company’s unique platform for eye disease
treatments is inherently flexible and intended to work with
established medicines, new formulations of medicines, as well as
future innovations such as gene therapy. Clearside is headquartered
in Alpharetta, GA. For more information, please visit
http://www.clearsidebio.com.
Investor and Media Contacts: Jenny Kobin (919)
423-4799Remy Bernarda (415) 203-6386 ir@clearsidebio.com
Source: Clearside Biomedical, Inc.
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024